Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Advanced Inhalation Therapies

Advanced Inhalation Therapies
2011 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
XAIR STOCK SYMBOL
1 INVESTMENTS
$4.03 SHARE PRICE (As of Friday Closing)
Description

Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company which develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 12 Eli Horovitz street
  • Rehovot 7608801
  • Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Advanced Inhalation Therapies’s full profile, request a free trial.

Advanced Inhalation Therapies Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.11 - $6.25 $43.3M $4.00 -$0.92 12.4K 10.7M

Advanced Inhalation Therapies Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 38,175 38,220 26,698
Revenue 8,997 7,724 0 0
EBITDA (9,215) (6,494) (17,991) (3,382)
Net Income (9,379) (6,558) (18,044) (3,720)
Total Assets 11,143 9,428 2,189 236
Total Debt 323 298 33 3,313
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Advanced Inhalation Therapies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Advanced Inhalation Therapies‘s full profile, request access.

Request full access to PitchBook

Advanced Inhalation Therapies Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Windtree Therapeutics Corporation Warrington, PA 00 00000 000000&0
000000000 Formerly VC-backed Lexington, MA 00 0000 000000000 0000
0000000000 0000000 Venture Capital-Backed Brighton, United Kingdom 0 000.00 00000000000 000.00
0000 000000000000 Venture Capital-Backed Austin, TX 0 000.00 00000000000 000.00
000000 Venture Capital-Backed Austin, TX 00 00000 000000000 00000
To view this company’s complete list of competitors, request access »

Advanced Inhalation Therapies Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 13-Jan-2017 000000000000000000 Social/Platform Software 000000 0000
To view this company’s complete investment and acquisition history, request access »

Advanced Inhalation Therapies Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Advanced Inhalation Therapies‘s full profile, request access.

Request full access to PitchBook

Advanced Inhalation Therapies Executive Team (12)

Name Title Board
Seat
Contact
Info
Steven Lisi Chief Executive Officer & Chairman
Amir Avniel Co-Founder, Chief Operating Officer & President
Douglas Beck Chief Financial Officer
David Greenberg MD Co-Founder & Medical Director
Duncan Fatkin Chief Commercial Officer

4 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

Advanced Inhalation Therapies Board Members (9)

Name Representing Role Since Contact
Info
Robert Carey Self Board Member 000 0000
Ron Bentsur Advanced Inhalation Therapies Board Member 000 0000
Steven Lisi Advanced Inhalation Therapies Chief Executive Officer & Chairman 000 0000

6 Former Board Members

You’re viewing 3 of 9 board members. Get the full list »